# Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions

> **NCT00233714** · PHASE1,PHASE2 · COMPLETED · sponsor: **Cordis US Corp.** · enrollment: 56 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** CYPHER Sirolimus-Eluting Coronary Stent
- **DEVICE:** CYPHER Sirolimus-Eluting Coronary Stent

## Key facts

- **NCT ID:** NCT00233714
- **Lead sponsor:** Cordis US Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05
- **Primary completion:** 2004-07
- **Final completion:** 2009-11
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2009-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00233714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00233714, "Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery Lesions". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT00233714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*